...
首页> 外文期刊>Journal of cardiac failure >Effects of Oral Supplementation With Nitrate-Rich Beetroot Juice in Patients With Pulmonary Arterial Hypertension—Results From BEET-PAH, an Exploratory Randomized, Double-Blind, Placebo-Controlled, Crossover Study
【24h】

Effects of Oral Supplementation With Nitrate-Rich Beetroot Juice in Patients With Pulmonary Arterial Hypertension—Results From BEET-PAH, an Exploratory Randomized, Double-Blind, Placebo-Controlled, Crossover Study

机译:口服补充剂对富含硝酸盐的甜菜汁患者患者肺动脉高压 - 结果来自BEET-PAH,探索性随机,双盲,安慰剂控制,交叉研究

获取原文
获取原文并翻译 | 示例
           

摘要

BackgroundThe nitrate–nitrite–nitric oxide (NO) pathway may represent a potential therapeutic target in patients with pulmonary arterial hypertension (PAH). We explored the effects of dietary nitrate supplementation, with the use of nitrate-rich beetroot juice (BRJ), in patients with PAH. Methods and ResultsWe prospectively studied 15 patients with PAH in an exploratory randomized, double-blind, placebo-controlled, crossover trial. The patients received nitrate-rich beetroot juice (~16 mmol nitrate per day) and placebo in 2 treatment periods of 7 days each. The assessments included; exhaled NO and NO flow–independent parameters (alveolar NO and bronchial NO flux), plasma and salivary nitrate and nitrite, biomarkers and metabolites of the NO-system, N-terminal pro–B-type natriuretic peptide, echocardiography, ergospirometry, diffusing capacity of the lung for carbon monoxide, and the 6-minute walk test. Compared with placebo ingestion of BRJ resulted in increases in; fractional exhaled NO at all flow-rates, alveolar NO concentrations and bronchial NO flux, and plasma and salivary levels of nitrate and nitrite. Plasma ornithine levels decreased and indices of relative arginine availability increased after BRJ compared to placebo. A decrease in breathing frequency was observed during ergospirometry after BRJ. A tendency for an improvement in right ventricular function was observed after ingestion of BRJ. In addition a tendency for an increase in the peak power output to peak oxygen consumption ratio (W peak/VO2peak) was observed, which became significant in patients reaching an increase of plasma nitrite >30% (responders). ConclusionsBRJ administered for 1 week increases pulmonary NO production and the relative arginine bioavailability in patients with PAH, compared with placebo. An increase in the W peak/VO2peak ratio was observed after BRJ ingestion in plasma nitrite responders. These findings indicate that supplementation with inorganic nitrate increase NO synthase–independent NO production from the nitrate-nitrite-NO pathway.
机译:背景技术硝酸亚硝酸盐一氧化物(NO)途径可以代表肺动脉高压患者(PAH)的潜在治疗靶标。我们探讨了饮食硝酸盐补充剂的影响,利用富含硝酸盐的甜菜汁(BRJ),在PAH患者中使用。方法和结果前瞻性研究了15名探索性随机,双盲,安慰剂控制,交叉试验的PAH患者。患者接受富含富含硝酸盐的甜菜汁(〜16mmol硝酸盐)和安慰剂,每次治疗时间为7天。评估包括;呼出的NO和无流动的参数(肺泡NO和支气管无通量),血浆和唾液硝酸盐和亚硝酸盐,生物标志物和No-System的代谢物,N-末端Pro-B型利钠肽,超声心动图,Ergospirometry,漫射能力一氧化碳的肺部,6分钟的步伐。与安慰剂摄入比较BRJ导致增加;分数呼出的不呼出,肺泡无浓度和支气管无通量,以及血浆和唾液水平的硝酸盐和亚硝酸盐。与安慰剂相比,血浆鸟氨酸水平降低和相对精氨酸可用性的相对精氨酸可用性增加。在BRJ之后在Ergospirometry期间观察到呼吸频率的降低。摄入BRJ后观察到右心室功能改善的趋势。此外,观察到达到峰值氧消耗比(W峰/ vo2peak)的峰值功率输出增加的趋势,这对于达到血浆亚硝酸盐的增加而变得显着> 30%(响应者)。结论与安慰剂相比,施用1周给药1周内的肺部不产生和PAH患者的相对精氨酸生物利用度。在血浆亚硝酸盐响应者中Brj摄入后观察到W峰/ vo2pak比的增加。这些发现表明,无机硝酸盐的补充不含来自硝酸亚硝酸盐 - 没有途径的合酶无关。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号